Overall result forecast presentation:	yes
Quantity performed reporting year:	161
Quantity forecast year:	92
Examination by state associations?	yes
Exemption?	no
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
29	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
22	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
22	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Drug therapy safety

Steering committee

Drug commission

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

Dok-ID 2309

11.11.2020

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Measures to minimise medication errors

Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Special instrument-based equipment

Research & teaching

Job

FL04 - Project-related cooperation with colleges and universities

Explanation

PD Dr. R. Dittrich Lernzentrum für individualisiertes medizinisches Tätigkeitstraining und Entwicklung für Studierende 4. Semester; Dr. ST. Lauer-Riffard Koop. mit Hochschule Osnabrück / Curtin University, Perth, Western Australia(Professor Brigitte Tampin);Kooperation Schmerztherapie UK Münster

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

PD Dr. H. Stubbe - UK Münster; PD Dr. St. Höll - UK Münster; PD Dr. R. Dittrich UK Münster; Dr. St. Lauer-Riffard UK Münster; Prof. Dr. med. Christoph Greiner UK Münster HS Osnabrück; Prof. Dr. med. habil. Dr. rer. medic. Dipl.-Biochem. Stroop, M.Sc. Medical School Hamburg UK Witten Herdecke

FL09 - Doctoral supervision

Explanation

PD. Dr. H. Stubbe; Prof. PD Dr. St. Höll; PD Dr. R. Dittrich; Dr. St. Lauer-Riffard; Prof. Dr. med. habil. Dr. rer. medic. Dipl.-Biochem. Stroop, M.Sc.

FL06 - Participation in multi-centre phase III/IV studies